Monroe Capital struggles with NAV declines, poor dividend coverage, and rate sensitivity despite a high yield and discount ...

Kevin De Bruyne, Myles Lewis-Skelly and Ben White are among the top players using a data company to give them an edge in ...

Q2 2025 Earnings Call Transcript August 1, 2025 Operator: Good morning, and welcome to Sixth Street Specialty Lending, Inc.’s ...

Discover how Obexelimab's unique B-cell inhibition and pivotal Phase 3 IgG4 results could drive Zenas BioPharma, Inc.'s ...

Detailed price information for Norwegian Cruise Ord (NCLH-N) from The Globe and Mail including charting and trades.

Second Quarter Consolidated Revenues of $2.53 billion, up 5% on a Reported basis and 4% on an Organic (non-GAAP)1 basis over the prior year period GAAP Net Income Attributable to Bausch Health ...

Detailed price information for Novo Resources Corp (NVO-T) from The Globe and Mail including charting and trades.

Research and development (R&D) expenses were $49.5 million for the second quarter of 2025, compared to $49.9 million for the comparable period in 2024. The decrease was primarily related to the ...

Operator: Thank you for standing by, and welcome to the Kiniksa Pharmaceutical Second Quarter 2025 Earnings Conference Call. [Operator Instructions] As a reminder, today ...